Loading...
XNYSAFL
Market cap57bUSD
Dec 24, Last price  
103.24USD
1D
0.49%
1Q
-5.88%
Jan 2017
196.67%
Name

Aflac Inc

Chart & Performance

D1W1MN
XNYS:AFL chart
P/E
12.31
P/S
3.07
EPS
8.39
Div Yield, %
1.68%
Shrs. gr., 5y
-5.02%
Rev. gr., 5y
-2.98%
Revenues
18.70b
-2.29%
13,281,000,00014,363,000,00014,616,000,00015,393,000,00016,554,000,00018,254,000,00020,732,000,00022,171,000,00025,364,000,00023,939,000,00022,728,000,00020,872,000,00022,559,000,00021,667,000,00021,758,000,00022,307,000,00022,147,000,00022,106,000,00019,140,000,00018,701,000,000
Net income
4.66b
+5.45%
1,299,000,0001,483,000,0001,483,000,0001,634,000,0001,254,000,0001,497,000,0002,344,000,0001,964,000,0002,866,000,0003,158,000,0002,951,000,0002,533,000,0002,659,000,0004,371,000,0002,920,000,0003,304,000,0004,778,000,0004,231,000,0004,418,000,0004,659,000,000
CFO
3.19b
-17.76%
4,486,000,0004,433,000,0004,397,000,0004,656,000,0004,965,000,0006,161,000,0006,989,000,00010,842,000,00014,952,000,00010,547,000,0006,550,000,0006,776,000,0005,987,000,0006,128,000,0006,014,000,0005,455,000,0005,958,000,0005,051,000,0003,879,000,0003,190,000,000
Dividend
Feb 19, 20250.58 USD/sh
Earnings
Jan 29, 2025

Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
URL
https://www.aflac.com/
IPO date
Jun 15, 1974
Employees
12,882
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
18,701,000
-2.29%
19,140,000
-13.42%
22,106,000
-0.19%
Cost of revenue
3,116,000
3,473,000
3,486,000
Unusual Expense (Income)
NOPBT
15,585,000
15,667,000
18,620,000
NOPBT Margin
83.34%
81.85%
84.23%
Operating Taxes
603,000
451,000
997,000
Tax Rate
3.87%
2.88%
5.35%
NOPAT
14,982,000
15,216,000
17,623,000
Net income
4,659,000
5.45%
4,418,000
4.42%
4,231,000
-11.45%
Dividends
(966,000)
(979,000)
(855,000)
Dividend yield
1.96%
2.13%
2.16%
Proceeds from repurchase of equity
(2,784,000)
(2,384,000)
(2,275,000)
BB yield
5.64%
5.20%
5.76%
Debt
Debt current
55,000
52,000
Long-term debt
7,488,000
7,589,000
8,073,000
Deferred revenue
(6,182,000)
(4,263,000)
Other long-term liabilities
97,375,000
84,520,000
(7,956,000)
Net debt
(23,520,000)
(167,928,000)
(217,921,000)
Cash flow
Cash from operating activities
3,190,000
3,879,000
5,051,000
CAPEX
Cash from investing activities
817,000
(1,540,000)
(2,378,000)
Cash from financing activities
(3,723,000)
(3,551,000)
(2,739,000)
FCF
14,490,000
15,224,000
17,686,000
Balance
Cash
28,223,000
79,684,000
103,747,000
Long term investments
2,785,000
95,888,000
122,299,000
Excess cash
30,072,950
174,615,000
224,940,700
Stockholders' equity
42,609,000
38,073,000
48,909,000
Invested Capital
96,651,050
85,544,000
87,788,000
ROIC
16.45%
17.56%
19.19%
ROCE
12.30%
12.07%
12.50%
EV
Common stock shares outstanding
598,745
637,655
676,729
Price
82.50
14.68%
71.94
23.21%
58.39
31.30%
Market cap
49,396,462
7.68%
45,872,901
16.09%
39,514,206
24.07%
EV
25,876,462
(122,055,099)
(178,406,794)
EBITDA
15,585,000
15,712,000
18,665,000
EV/EBITDA
1.66
Interest
195,000
226,000
238,000
Interest/NOPBT
1.25%
1.44%
1.28%